Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
about
Contribution of intestinal barrier damage, microbial translocation and HIV-1 infection status to an inflammaging signatureRegulation of muscle protein synthesis during sepsis and inflammation.Lack of PPARα exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stressIntensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shockPeroxisome proliferator-activated receptor α activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway.Reduced peroxisome proliferator-activated receptor α expression is associated with decreased survival and increased tissue bacterial load in sepsis.Inhibition of glycogen synthase kinase 3β promotes autophagy to protect mice from acute liver failure mediated by peroxisome proliferator-activated receptor α.PPAR-gamma agonist protects against intestinal injury during necrotizing enterocolitisPersonalized identification of differentially expressed pathways in pediatric sepsis.MNK2 inhibits eIF4G activation through a pathway involving serine-arginine-rich protein kinase in skeletal muscle.Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice studyDownregulated Translation Initiation Signaling Predisposes Low-Birth-Weight Neonatal Pigs to Slower Rates of Muscle Protein Synthesis.Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP.Peroxisome proliferator-activated receptors in HCV-related infectionPPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure.Expression and phosphorylation of eukaryotic translation initiation factor 4-gamma (eIF4G) in denervated atrophic and hypertrophic mouse skeletal muscle.
P2860
Q33599291-5B01D8BF-C5D3-4D20-8D58-26C8EA583B61Q34628735-5AA54218-73B5-44D3-ABB4-D3C4DF17E86EQ34664393-AC1A62D3-046A-4985-AB58-6F3B7C0C572CQ34697264-3DD4BEB8-E5CA-42B4-9257-CCD55B7ED796Q35679584-AD3B8EF3-993A-4C87-BF2F-E33C6D94B81AQ35680924-6289D9E6-02C2-4DF3-8589-DEACC759A9E3Q36775015-A006D818-C3B6-4626-B34B-73F043BF03B4Q37121019-F7C6A541-1CBF-41B7-92BB-5268FA945D9DQ38604584-A7BE6A70-7570-4BC8-98CB-2B51160EC62CQ39396142-BC3DB0A8-1E7C-4879-AB17-9BE41A5DA62EQ39767528-0A566609-787D-4234-B98D-173954BF71F2Q40975114-DCEF0559-ACBF-4036-A200-9CEE5AA63A4DQ41782419-ABFBBFB0-F48B-43D3-AB51-C16CBCA26E39Q41814535-E72D258F-780B-424E-93E8-A5CAC2E2B2FBQ42066636-0DDDDE04-685C-44DC-98C8-F4D3A12A06EBQ48517132-184C2BEB-551F-4D10-9D88-E9DE51723D49
P2860
Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Absence of peroxisome prolifer ...... an failure induced by zymosan.
@en
Absence of peroxisome proliferators-activated receptors
@nl
type
label
Absence of peroxisome prolifer ...... an failure induced by zymosan.
@en
Absence of peroxisome proliferators-activated receptors
@nl
prefLabel
Absence of peroxisome prolifer ...... an failure induced by zymosan.
@en
Absence of peroxisome proliferators-activated receptors
@nl
P2093
P50
P1433
P1476
Absence of peroxisome prolifer ...... an failure induced by zymosan.
@en
P2093
Carmelo Muià
Concetta Crisafulli
Edoardo Sessa
Emanuela Esposito
Giuseppe Malleo
Rosaria Meli
P304
P356
10.1097/01.SHK.0000230299.78515.2C
P577
2006-11-01T00:00:00Z